More News! Biotechs Push G20 for Support in Battle against Antibiotic Resistance

Try as we might, we can’t cover all the biotech news out there! Here’s a roundup of news that didn’t make the cut this week.

Marco Diaz Segura
  • Immunocore has identified a third target in its discovery collaboration with GSK
  • Seventure and Novartis went in on a $13.2M financing round for a new Japanese microbiome company
  • Sygnis acquired Innova Biosciences for €10.8M
Oleksii G
  • ASIT Bio is progressing through Phase III following encouraging immunogenicity data
  • Onxeo reported preclinical results that open the door to easy systemic administration of its AsiDNA anti-DNA repair cancer treatment

Brian Lasenby

  • The BEAM Alliance (Biotech companies in Europe combatting AntiMicrobial resistance) is urging leaders at G20 this week to support its fight against deadly superbugs

Images from Brian Lasenby, Nirun Thuwasin, Marco Diaz Segura, Oleksii G, Janossy Gergely, Vladimir Wrangel /

Let's Continue The Conversation

Feel free to send us comments about this article to [email protected] and/or comment on that article on social media.

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.